Salus Science Corporation HOME | サルスサイエンス株式会社

Pioneering the
Future of
Pancreatic Cancer
Research

Promoting Pancreatic Cancer Research
toward Realization of Clinical Application

Did you know that the 5-year survival rate for pancreatic cancer is 9%?

This percentage indicates that the prognosis of pancreatic cancer is worse than that of other cancers. We would like to help open up the possibility of establishing a new diagnosis and treatment system for pancreatic cancer by putting the results of our pancreatic cancer research to practical use in order to realize early detection and early treatment of pancreatic cancer.

We will continue to take on challenges and move forward to realize a future in which pancreatic cancer, which is intractable, can be conquered.

Salus Science involved
in a variety of initiatives